- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04587076
Evaluation of Protein Intake and Micronutrient Supplementation After Bariatric Surgery (BOP)
October 7, 2020 updated by: University Medicine Greifswald
Evaluation of Protein Intake, Vitamin, Mineral, and Trace Element Supplementation After Bariatric Surgery According to the German S3 Guidelines - What Effects do Age, Sex, and Socio-economic Status Have on Adherence?
Obesity is a chronic disease in which accumulation of excess body fat can result in impaired health.
In cases of severe obesity, weight loss surgery can be necessary as a treatment.
There are different forms of surgery but the common basic principle is to restrict food intake and decrease the absorption of food in the stomach and intestines.
As a consequence, there is a higher risk of developing nutrient deficiency after surgery and supplementation of protein, vitamins, and minerals can be necessary.
This study evaluates intakes of protein, vitamins, and minerals in patients with weight loss surgery and compares them to recommended intakes.
Further, this study looks at the role of age, sex, and socioeconomic status in this context.
Study Overview
Status
Completed
Detailed Description
Obesity is defined by the World Health Organization as abnormal or excessive fat accumulation that may impair health.
These days, bariatric surgery is considered the most effective treatment of morbid obesity.
In the last decade, the number of bariatric surgeries performed worldwide constantly increased.
Common bariatric surgery procedures include gastric bypass, sleeve gastrectomy, adjustable gastric band, and biliopancreatic diversion with duodenal switch.
After surgery, weight loss is induced by a reduced food volume the stomach can hold, malabsorption of nutrients, or by a combination of both mechanisms.
In consequence, patients with bariatric surgery have an increased risk of developing nutrient deficiency.
Therefore, guidelines recommend supplementation of critical nutrients, i.e. protein, vitamins, and minerals, after bariatric surgery.
This study assesses intake of these nutrients in patients with bariatric surgery based on the recommendations provided by the German S3 Guideline Group on the Surgical Treatment of Obesity and Metabolic Diseases.
In particular, this study assesses the association of therapy adherence with age, sex, and socioeconomic status.
Study Type
Observational
Enrollment (Actual)
38
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Greifswald, Germany
- University Medicine Greifswald
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients were recruited at University Medicine Greifswald, a medical center with expertise in obesity Treatment located in Northeast Germany.
Patients meeting the study's eligibilty criteria who attended their routine postoperative care visits after bariatric surgery were approached for study participation.
Description
Inclusion Criteria:
- Sleeve gastrectomy (postoperative)
- Roux-en-Y gastric Bypass (postoperative)
- Postoperative period > 6 month
Exclusion Criteria:
- Missing consent
- Pregnancy
- Malignant tumor
- Implanted pacemaker
- Any other serious primary disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Therapy Adherence Across Groups of Socio-Economic Status
Time Frame: Baseline
|
Number of recommendations followed by the patients according to the recommendations provided by the German S3 Guidelines across groups of socio-economic status.
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Therapy Adherence Across Age Groups
Time Frame: Baseline
|
Number of recommendations followed by the patients according to the recommendations provided by the German S3 Guidelines across age groups.
|
Baseline
|
|
Therapy Adherence Across Sexes
Time Frame: Baseline
|
Number of recommendations followed by the patients according to the recommendations provided by the German S3 Guidelines across sexes.
|
Baseline
|
|
Improvement of Deficiency Symptoms
Time Frame: Baseline
|
Determination of improvement of deficiency symptoms through adequate supplementation after bariatric surgery
|
Baseline
|
|
Body Weight
Time Frame: Baseline
|
Determination of body weight measured in kilograms
|
Baseline
|
|
Body Height
Time Frame: Baseline
|
Determination of body height measured in centimeters
|
Baseline
|
|
Body Mass Index
Time Frame: Baseline
|
Determination of body mass index measured in kg/m^2 (calculated from the values obtained for body weight and height)
|
Baseline
|
|
Waist Circumference
Time Frame: Baseline
|
Determination of waist circumference measured in centimeters
|
Baseline
|
|
Hip Circumference
Time Frame: Baseline
|
Determination of hip circumference measured in centimeters
|
Baseline
|
|
Waist-to-Hip Ratio
Time Frame: Baseline
|
Determination of waist-to-hip ratio (calculated from the values obtained for waist and hip circumference)
|
Baseline
|
|
Triceps Skinfold Thickness
Time Frame: Baseline
|
Determination of triceps skinfold thickness measured in millimeters
|
Baseline
|
|
Upper Arm Circumference
Time Frame: Baseline
|
Determination of upper arm circumference measured in centimeters
|
Baseline
|
|
Fat Free Mass
Time Frame: Baseline
|
Determination of fat free mass measured by Bioelectrical Impedance Analysis (BIA)
|
Baseline
|
|
Skeletal Muscle Mass
Time Frame: Baseline
|
Determination of skeletal muscle mass measured by Bioelectrical Impedance Analysis (BIA)
|
Baseline
|
|
Fat Mass
Time Frame: Baseline
|
Determination of fat mass measured by Bioelectrical Impedance Analysis (BIA)
|
Baseline
|
|
Total Body Water
Time Frame: Baseline
|
Determination of total body water measured by Bioelectrical Impedance Analysis (BIA)
|
Baseline
|
|
Extracellular Water
Time Frame: Baseline
|
Determination of extracellular water measured by Bioelectrical Impedance Analysis (BIA)
|
Baseline
|
|
Phase Angle
Time Frame: Baseline
|
Determination of phase angle measured by Bioelectrical Impedance Analysis (BIA)
|
Baseline
|
|
Muscle Strength
Time Frame: Baseline
|
Determination of muscle strength assessed by handgrip dynamometry
|
Baseline
|
|
Systolic Blood Pressure
Time Frame: Baseline
|
Determination of systolic blood pressure in mmHg
|
Baseline
|
|
Diastolic Blood Pressure
Time Frame: Baseline
|
Determination of diastolic blood pressure in mmHg
|
Baseline
|
|
Physical Activity
Time Frame: Baseline
|
Determination of metabolic equivalents of task per day and activity level assessed by employment of the German version of the International Physical Activity Questionnaire (IPAQ) Short Form
|
Baseline
|
|
Energy Intake
Time Frame: Baseline
|
Determination of energy intake (kcal/d) assessed by 7-day dietary record
|
Baseline
|
|
Protein Intake
Time Frame: Baseline
|
Determination of protein intake assessed by 7-day dietary record
|
Baseline
|
|
Fat Intake
Time Frame: Baseline
|
Determination of fat intake assessed by 7-day dietary record
|
Baseline
|
|
Omega-3 Fatty Acid Intake
Time Frame: Baseline
|
Determination of omega-3 fatty acid intake assessed by 7-day dietary record
|
Baseline
|
|
Omega-6 Fatty Acid Intake
Time Frame: Baseline
|
Determination of omega-6 fatty acid intake assessed by 7-day dietary record
|
Baseline
|
|
Carbohydrate Intake
Time Frame: Baseline
|
Determination of carbohydrate intake assessed by 7-day dietary record
|
Baseline
|
|
Dietary Fiber Intake
Time Frame: Baseline
|
Determination of dietary fiber intake assessed by 7-day dietary record
|
Baseline
|
|
Sucrose Intake
Time Frame: Baseline
|
Determination of sucrose intake intake assessed by 7-day dietary record
|
Baseline
|
|
Alcohol Intake
Time Frame: Baseline
|
Determination of alcohol intake intake assessed by 7-day dietary record
|
Baseline
|
|
Diet Quality
Time Frame: Baseline
|
Determination of diety quality assessed by 7-day dietary record based on the Alternate Healthy Eating Index 2010 (AHEI-2010) score.
Scores range from 0 to 110, with higher scores indicating higher diet quality
|
Baseline
|
|
Quality of Life Assessment
Time Frame: Baseline
|
Quality of life was assessed by employment of the German Short Form-12 Questionnaire, with higher scores indicating better quality of life.
|
Baseline
|
|
Intestinal Microbiome
Time Frame: Baseline
|
Determination of intestinal microbiome composition in comparison to healthy control subjects
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 3, 2019
Primary Completion (Actual)
September 30, 2019
Study Completion (Actual)
September 30, 2019
Study Registration Dates
First Submitted
October 7, 2020
First Submitted That Met QC Criteria
October 7, 2020
First Posted (Actual)
October 14, 2020
Study Record Updates
Last Update Posted (Actual)
October 14, 2020
Last Update Submitted That Met QC Criteria
October 7, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BB 080/19
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly